84460-89-9Tetrahydrozoline Related Compound E
● In Stock
| Catalogue No.: | VE0022667 |
|---|---|
| CAS No.: | 84460-89-9 |
| Mol. Formula: | C13H18N2O |
| Mol. Weight: | 218.3 g/mol |
Additional information on CAS 84460-89-9
Parent drug
TetrahydrozolineIUPAC Name
N-(2-Aminoethyl)-1,2,3,4-tetrahydronaphthalene-1-carboxamidePharmacopoeial Synonyms
N/AOther Synonyms
N-(2-Aminoethyl)-1, 2, 3, 4-tetrahydro-1-naphthalenecarboxamide Hydrochloride; ((1, 2, 3, 4-Tetrahydro-1-naphthyl)formylethylenediamine Hydrochloride)Smiles
O=C(C1CCCC2=C1C=CC=C2)NCCNInChI
InChI=1S/C13H18N2O/c14-8-9-15-13(16)12-7-3-5-10-4-1-2-6-11(10)12/h1-2, 4, 6, 12H, 3, 5, 7-9, 14H2, (H, 15, 16)Description
Tetrahydrozoline Related Compound E, CAS 84460-89-9, is a structurally defined process-related impurity associated with the imidazoline vasoconstrictor scaffold. With molecular formula C13H18N2O and molecular weight 218.3 g/mol, it represents a neutral heteroaromatic impurity rather than a salt form. Its occurrence is typically linked to side-reaction pathways during synthesis or to oxidative and rearrangement transformations of tetrahydrozoline intermediates. Because trace-level determination may be required in impurity profiling, characterization commonly relies on LC-MS/MS, high-resolution LC-MS, and complementary NMR or HPLC-UV methods. Regulatory assessment focuses on structural qualification and specification control under impurity control frameworks.Request a Quote
"*" indicates required fields




